Global Certificate Course in Pharmacogenomics for Aging

About this Podcast

HOST: Welcome to our podcast, today we're talking with Dr. Geneva Smith, an expert in pharmacogenomics and the course "Global Certificate Course in Pharmacogenomics for Aging." Dr. Smith, welcome! GUEST: Thank you, I'm thrilled to be here! HOST: Dr. Smith, could you share a bit about your experience and what led you to be so passionate about pharmacogenomics, especially as it applies to aging populations? GUEST: Absolutely! I've spent over 20 years working in geriatric pharmacotherapy, and I've seen firsthand how genetic testing and tailored therapies can significantly improve patient outcomes, particularly in the elderly. HOST: That's fascinating! With the aging population growing rapidly, what current trends are you seeing in pharmacogenomics that could benefit this group? GUEST: We're seeing more widespread use of genetic testing, which allows for more personalized medication management, reducing adverse effects and improving drug efficacy in older adults. HOST: That sounds promising. But there must be challenges too. What are some common obstacles you face when implementing pharmacogenomics in an aging population? GUEST: A major challenge is healthcare providers' understanding and comfort with pharmacogenomics. Many are not yet familiar with the applications or the interpretation of test results, which can hinder its implementation. HOST: As we look to the future, what advancements or changes do you envision for pharmacogenomics, especially for aging populations? GUEST: I believe we'll see pharmacogenomics integrated into standard care for older adults, with genetic testing becoming as routine as other diagnostic tests. This will allow for truly personalized medicine and improved patient outcomes. HOST: Dr. Smith, thank you for your insights. Today we've learned about the exciting potential of pharmacogenomics in aging populations and the challenges ahead. Join us in exploring and advancing your career with the "Global Certificate Course in Pharmacogenomics for Aging." Sign up now and stay at the forefront of this evolving field. GUEST: Thank you, it was a pleasure discussing this important topic with you!